PRIMARY ARGON-LASER TRABECULOPLASTY VS PILOCARPINE .2. LONG-TERM EFFECTS ON INTRAOCULAR-PRESSURE AND FACILITY OF OUTFLOW - STUDY DESIGN ANDADDITIONAL THERAPY
B. Bergea et al., PRIMARY ARGON-LASER TRABECULOPLASTY VS PILOCARPINE .2. LONG-TERM EFFECTS ON INTRAOCULAR-PRESSURE AND FACILITY OF OUTFLOW - STUDY DESIGN ANDADDITIONAL THERAPY, Acta ophthalmologica, 72(2), 1994, pp. 145-154
In a prospective study 82 patients recently diagnosed with simple or c
apsular glaucoma were randomized to receive primary argon laser trabec
uloplasty or pilocarpine treatment. A 2-year follow-up showed a better
success rate in the laser group, with less need for additional therap
y. The average intraocular pressure and peak pressure was lower and th
e daytime pressure variation was significantly less in the laser group
. The better increase in facility of outflow in the laser group was no
t statistically significant. In capsular glaucoma, laser treatment res
ulted in a significantly lower average pressure than with medication.
In simple glaucoma the effect was about the same in the two treatment
groups. Increase in facility of outflow was significantly better in si
mple glaucoma than in capsular glaucoma. High initial intraocular pres
sure gave a significantly lower success rate. Primary argon laser trab
eculoplasty as a single glaucoma treatment seems advantageous in compa
rison to medication with pilocarpine for regulating intraocular pressu
re.